Skip to main content
Top
Published in: Rheumatology International 11/2012

01-11-2012 | Original Article

Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China

Authors: Xin Tang, Zongke Zhou, Bin Shen, Jing Yang, Pengde Kang, Jian Li, Nicolas Crook, Qi Li, Li Min, Fuxing Pei

Published in: Rheumatology International | Issue 11/2012

Login to get access

Abstract

The aim of the study was to detect differences in serum levels of interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), cartilage oligomeric matrix protein (COMP), type II collagen (CTX-II) between patients with Kashin-Beck disease (KBD) or osteoarthritis (OA) and to assess the correlation between these differences with the clinical grade of KBD. A total of one hundred fifty adult serum samples were collected; these samples belonged to the KBD group (n = 64), the OA group in KBD-prevalent areas (n = 47) and a healthy control group in non-KBD area (n = 39). Serum levels of TNF-α, IL-1β, COMP, and CTX–II were determined by a sandwich enzyme-linked immunosorbent assay, and the results were compared among the 3 groups (KBD/OA/normal) and between the different grades of KBD as well. The serum levels of IL-1β, TNF-α, COMP, and CTX-II were significantly higher in the KBD and OA group than the healthy adult group (P < 0.001), and TNF-α and IL-1β levels in the KBD group were similar to the OA group (for TNF-α, 14.38 ± 7.42 pg/ml vs. 12.61 ± 4.00 pg/ml, respectively, [P = 0.29]; for IL-1β, 141.53 ± 71.35 pg/ml vs. 135.61 ± 68.60 pg/ml, respectively, [P = 0.63]). However, the COMP level was significantly lower and the CTX-II level was higher in the KBD group than in the OA group (for COMP, 7.03 ± 3.11 ng/ml vs. 9.20 ± 3.51 ng/ml, respectively, [P = 0.003]; for CTX-II, 2.23 ± 0.79 ng/ml vs. 1.80 ± 0.87 ng/ml, respectively, [P = 0.026]). Moreover, no significant correlations were found between clinical grade and serum levels of TNF-α, IL-1β, COMP, and CTX-II for the 3 grades of KBD patients (P = 0.645, 0.481, 0.832, and 0.270, respectively). This study showed that serum levels of COMP in KBD patients decreased and CTX-II levels increased compared with the levels in OA patients, but TNF-α and IL-1β levels in KBD and OA group were similar. In addition, increased serum levels of TNF-α, IL-1β, COMP, and CTX-II were not associated with the KBD grade.
Literature
1.
go back to reference Ministry of Public Health, Development, Reformation Committee, Ministry of Finance (2004) China national intensive endemic prevention and control project. Ministry of Public Health, Development, Reformation Committee, Ministry of Finance, Beijing Ministry of Public Health, Development, Reformation Committee, Ministry of Finance (2004) China national intensive endemic prevention and control project. Ministry of Public Health, Development, Reformation Committee, Ministry of Finance, Beijing
2.
go back to reference Yang J (1998) Mechanisms in occurrence and prevalence of Kashin-Beck disease (KBD). Chin J Endemiol 17:201–206 Yang J (1998) Mechanisms in occurrence and prevalence of Kashin-Beck disease (KBD). Chin J Endemiol 17:201–206
3.
go back to reference Zou K, Liu G, Wu T et al (2009) Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthr Cartil 17(2):144–151PubMedCrossRef Zou K, Liu G, Wu T et al (2009) Selenium for preventing Kashin-Beck osteoarthropathy in children: a meta-analysis. Osteoarthr Cartil 17(2):144–151PubMedCrossRef
4.
go back to reference Chasseur C, Suetens C, Michel V et al (2001) A 4-year study of the mycological aspects of Kashin-Beck disease in Tibet. Int Orthop 25(3):154–158PubMedCrossRef Chasseur C, Suetens C, Michel V et al (2001) A 4-year study of the mycological aspects of Kashin-Beck disease in Tibet. Int Orthop 25(3):154–158PubMedCrossRef
5.
go back to reference Hinsenkamp M, Mathieu F, Claus W et al (2009) Effects of physical environment on the evolution of Kashin-Beck disease in Tibet. Int Orthop 33(4):1085–1088PubMedCrossRef Hinsenkamp M, Mathieu F, Claus W et al (2009) Effects of physical environment on the evolution of Kashin-Beck disease in Tibet. Int Orthop 33(4):1085–1088PubMedCrossRef
6.
go back to reference Fang W, Wu P, Hu R et al (2003) Environmental Se-Mo-B deficiency and its possible effects on crops and Keshan-Beck disease (KBD) in the Chousang area, Yao County, Shaanxi Province, China. Environ Geochem Health 25(2):267–280PubMedCrossRef Fang W, Wu P, Hu R et al (2003) Environmental Se-Mo-B deficiency and its possible effects on crops and Keshan-Beck disease (KBD) in the Chousang area, Yao County, Shaanxi Province, China. Environ Geochem Health 25(2):267–280PubMedCrossRef
7.
go back to reference Wang WZ, Guo X, Duan C et al (2009) Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthr Cartil 17(1):83–90PubMedCrossRef Wang WZ, Guo X, Duan C et al (2009) Comparative analysis of gene expression profiles between the normal human cartilage and the one with endemic osteoarthritis. Osteoarthr Cartil 17(1):83–90PubMedCrossRef
8.
go back to reference Xiong YM, Mo XY, Zou XZ et al (2010) Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease. Osteoarthr Cartil 18(6):817–824PubMedCrossRef Xiong YM, Mo XY, Zou XZ et al (2010) Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease. Osteoarthr Cartil 18(6):817–824PubMedCrossRef
9.
go back to reference Kravchenko LF (1976) Clinical course of Kashine Beck disease. Vopr Revm 3:43–51PubMed Kravchenko LF (1976) Clinical course of Kashine Beck disease. Vopr Revm 3:43–51PubMed
10.
go back to reference Ping ZG, Guo X, Wang FQ et al (2004) Epidemiological characters of Kashin-Beck disease in nuclear families. Zhonghua Liu Xing Bing Xue Za Zhi 25(10):848–851PubMed Ping ZG, Guo X, Wang FQ et al (2004) Epidemiological characters of Kashin-Beck disease in nuclear families. Zhonghua Liu Xing Bing Xue Za Zhi 25(10):848–851PubMed
11.
go back to reference Cao J, Li S, Shi Z et al (2008) Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. Osteoarthr Cartil 16(6):680–688PubMedCrossRef Cao J, Li S, Shi Z et al (2008) Articular cartilage metabolism in patients with Kashin-Beck Disease: an endemic osteoarthropathy in China. Osteoarthr Cartil 16(6):680–688PubMedCrossRef
12.
go back to reference Happonen KE, Saxne T, Aspberg A et al (2010) Regulation of complement by COMP allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthr Rheum 62(12):3574–3583CrossRef Happonen KE, Saxne T, Aspberg A et al (2010) Regulation of complement by COMP allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthr Rheum 62(12):3574–3583CrossRef
13.
go back to reference Salminen H, Perälä M, Lorenzo P et al (2000) Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthr Rheum 43(8):1742–1748CrossRef Salminen H, Perälä M, Lorenzo P et al (2000) Up-regulation of cartilage oligomeric matrix protein at the onset of articular cartilage degeneration in a transgenic mouse model of osteoarthritis. Arthr Rheum 43(8):1742–1748CrossRef
14.
go back to reference Kawashiri SY, Kawakami A, Ueki Y et al (2010) Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab. Joint Bone Spine 77(5):418–420PubMedCrossRef Kawashiri SY, Kawakami A, Ueki Y et al (2010) Decrement of serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis (RA) patients achieving remission after 6 months of etanercept treatment: comparison with CRP, IgM-RF, MMP-3 and anti-CCP Ab. Joint Bone Spine 77(5):418–420PubMedCrossRef
15.
go back to reference Sharif M, Kirwan J, Charni N et al (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis–association with disease progression. Rheumatology 46(6):938–943PubMedCrossRef Sharif M, Kirwan J, Charni N et al (2007) A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis–association with disease progression. Rheumatology 46(6):938–943PubMedCrossRef
16.
go back to reference Reijman M, Hazes JM, Bierma-Zeinstra SM et al (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthr Rheum 50(8):2471–2478CrossRef Reijman M, Hazes JM, Bierma-Zeinstra SM et al (2004) A new marker for osteoarthritis: cross-sectional and longitudinal approach. Arthr Rheum 50(8):2471–2478CrossRef
17.
go back to reference Kimura M, Matsukawa A, Ohkawara S et al (1997) Blocking of TNF-alpha and IL-1 inhibits leukocyte infiltration at early, but not at late grade of S. aureus-induced arthritis and the concomitant cartilagedestruction in rabbits. Clin Immunol Immunopathol 82(1):18–25PubMedCrossRef Kimura M, Matsukawa A, Ohkawara S et al (1997) Blocking of TNF-alpha and IL-1 inhibits leukocyte infiltration at early, but not at late grade of S. aureus-induced arthritis and the concomitant cartilagedestruction in rabbits. Clin Immunol Immunopathol 82(1):18–25PubMedCrossRef
18.
go back to reference Wilbrink B, Nietfeld JJ, den Otter W et al (1991) Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol 30(4):265–271PubMedCrossRef Wilbrink B, Nietfeld JJ, den Otter W et al (1991) Role of TNF alpha, in relation to IL-1 and IL-6 in the proteoglycan turnover of human articular cartilage. Br J Rheumatol 30(4):265–271PubMedCrossRef
19.
go back to reference Wang W, Guo X, Chen J et al (2008) Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck Disease. J Rheumatol 35(4):696–702PubMed Wang W, Guo X, Chen J et al (2008) Morphology and phenotype expression of types I, II, III, and X collagen and MMP-13 of chondrocytes cultured from articular cartilage of Kashin-Beck Disease. J Rheumatol 35(4):696–702PubMed
20.
go back to reference Yang TF, Wang G, Tong W et al (2001) Measurement of the bioactivity of interleukin and tumour necrosis factor in synovial fluid of Kashin-Beck disease. Int Orthop 25(3):162–163PubMedCrossRef Yang TF, Wang G, Tong W et al (2001) Measurement of the bioactivity of interleukin and tumour necrosis factor in synovial fluid of Kashin-Beck disease. Int Orthop 25(3):162–163PubMedCrossRef
21.
go back to reference Wu YH, Lucke A, Jin ZD et al (2006) Holocene climate development on the central Tibetan Plateau: a sedimentary record from Cuoe Lake. Palaeogeogr Palaeoclimatol Palaeoecol 234:328–340CrossRef Wu YH, Lucke A, Jin ZD et al (2006) Holocene climate development on the central Tibetan Plateau: a sedimentary record from Cuoe Lake. Palaeogeogr Palaeoclimatol Palaeoecol 234:328–340CrossRef
22.
go back to reference Bai A, Zhai PM, Liu XD (2007) Climatology and trends of wet spells in China. Theor Appl Climatol 88:139–148CrossRef Bai A, Zhai PM, Liu XD (2007) Climatology and trends of wet spells in China. Theor Appl Climatol 88:139–148CrossRef
23.
go back to reference Li F, Deng J, Zhou D et al (2005) Analysis on monitoring data of Kashin-Beck Disease in Sichuan province in 2005. J Preven Med Inform 21(6):666–668 Li F, Deng J, Zhou D et al (2005) Analysis on monitoring data of Kashin-Beck Disease in Sichuan province in 2005. J Preven Med Inform 21(6):666–668
24.
go back to reference Yang JB, Wang ZW, Liu JX (1994) Diagnostic criteria of Kashin-Beck disease. Chin J Endemiol 13(5):24–32 Yang JB, Wang ZW, Liu JX (1994) Diagnostic criteria of Kashin-Beck disease. Chin J Endemiol 13(5):24–32
25.
go back to reference Xiong G (2001) Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 25(3):147–150PubMedCrossRef Xiong G (2001) Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 25(3):147–150PubMedCrossRef
26.
go back to reference Hinton R, Moody RL, Davis AW et al (2002) Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician 65(5):841–848PubMed Hinton R, Moody RL, Davis AW et al (2002) Osteoarthritis: diagnosis and therapeutic considerations. Am Fam Physician 65(5):841–848PubMed
27.
go back to reference Yang J (2005) The discussion on the medication for adult Kaschin-Beck disease. Chin J Endemic 24(1):87–90 Yang J (2005) The discussion on the medication for adult Kaschin-Beck disease. Chin J Endemic 24(1):87–90
28.
go back to reference Duan C, Guo X, Zhang XD et al (2010) Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. Arthr Rheum 62(3):771–780CrossRef Duan C, Guo X, Zhang XD et al (2010) Comparative analysis of gene expression profiles between primary knee osteoarthritis and an osteoarthritis endemic to Northwestern China, Kashin-Beck disease. Arthr Rheum 62(3):771–780CrossRef
29.
go back to reference Wang SJ, Guo X, Zuo H et al (2006) Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with KashineBeck disease. J Rheumatol 33(3):615–619PubMed Wang SJ, Guo X, Zuo H et al (2006) Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with KashineBeck disease. J Rheumatol 33(3):615–619PubMed
30.
go back to reference Vilím V, Olejárová M, Machácek S et al (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthr Cartil 10(9):707–713PubMedCrossRef Vilím V, Olejárová M, Machácek S et al (2002) Serum levels of cartilage oligomeric matrix protein (COMP) correlate with radiographic progression of knee osteoarthritis. Osteoarthr Cartil 10(9):707–713PubMedCrossRef
31.
go back to reference Tseng S, Reddi H, Di Cesare PE (2009) Cartilage oligomeric matrix protein (COMP): a biomarker of arthritis. Biomark Insights 4:33–44PubMed Tseng S, Reddi H, Di Cesare PE (2009) Cartilage oligomeric matrix protein (COMP): a biomarker of arthritis. Biomark Insights 4:33–44PubMed
32.
go back to reference Chevalier X, Conrozier T (2005) Biological markers for osteoarthritis:an update. Joint Bone Spine 72(2):106–109PubMedCrossRef Chevalier X, Conrozier T (2005) Biological markers for osteoarthritis:an update. Joint Bone Spine 72(2):106–109PubMedCrossRef
33.
go back to reference Dam EB, Byrjalsen I, Karsdal MA et al (2009) Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthr Cartil 17(3):384–389PubMedCrossRef Dam EB, Byrjalsen I, Karsdal MA et al (2009) Increased urinary excretion of C-telopeptides of type II collagen (CTX-II) predicts cartilage loss over 21 months by MRI. Osteoarthr Cartil 17(3):384–389PubMedCrossRef
34.
go back to reference Garnero P, Ayral X, Rousseau JC et al (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthr Rheum 46(10):21–30CrossRef Garnero P, Ayral X, Rousseau JC et al (2002) Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthr Rheum 46(10):21–30CrossRef
35.
go back to reference Aigner T, Kurz B, Fukui N et al (2002) Roles of chondrocytes in the pathogenesis of osteoarthritis. Curr Opin Rheumatol 14(5):578–584PubMedCrossRef Aigner T, Kurz B, Fukui N et al (2002) Roles of chondrocytes in the pathogenesis of osteoarthritis. Curr Opin Rheumatol 14(5):578–584PubMedCrossRef
36.
go back to reference Goldring SR, Goldring MB (2004) The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop 427:S27–S36PubMedCrossRef Goldring SR, Goldring MB (2004) The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop 427:S27–S36PubMedCrossRef
37.
go back to reference Yan D, Kang P, Shen B et al (2010) Serum levels of IL-1β, IL-6 and TNF-α in rats fed with Kashin-Beck disease-affected diet. Int J Rheum Dis 13(4):406–411PubMedCrossRef Yan D, Kang P, Shen B et al (2010) Serum levels of IL-1β, IL-6 and TNF-α in rats fed with Kashin-Beck disease-affected diet. Int J Rheum Dis 13(4):406–411PubMedCrossRef
38.
go back to reference Stannus O, Jones G, Cicuttini F et al (2010) Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr Cartil 18(11):1441–1447PubMedCrossRef Stannus O, Jones G, Cicuttini F et al (2010) Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthr Cartil 18(11):1441–1447PubMedCrossRef
39.
go back to reference Chaganti RK, Kelman A, Lui L et al (2008) Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthr Cartil 16(5):566–571PubMedCrossRef Chaganti RK, Kelman A, Lui L et al (2008) Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthr Cartil 16(5):566–571PubMedCrossRef
Metadata
Title
Serum levels of TNF-α, IL-1β, COMP, and CTX-II in patients with Kashin-Beck disease in Sichuan, China
Authors
Xin Tang
Zongke Zhou
Bin Shen
Jing Yang
Pengde Kang
Jian Li
Nicolas Crook
Qi Li
Li Min
Fuxing Pei
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2172-8

Other articles of this Issue 11/2012

Rheumatology International 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.